Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation

Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kohei, Naka, Megumi, Ito, Takanori, Kanai, Osamu, Maekawa, Koichi, Nakatani, Koichi, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024693/
https://www.ncbi.nlm.nih.gov/pubmed/33854939
http://dx.doi.org/10.1016/j.rmcr.2021.101393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024693/
https://www.ncbi.nlm.nih.gov/pubmed/33854939
http://dx.doi.org/10.1016/j.rmcr.2021.101393

Ejemplares similares